Articles tagged "Liver transplantation"

2019 American Transplant Congress
Impact of Enteric Vancomycin Resistant Enterococcus Colonization on Waitlist Outcomes among Liver Transplant Candidates
E. Aldag, R. Pedersen, V. Gunabushanam, A. Sahajpal, T. J. Dilworth
Aurora St Luke's Medical Center, Milwaukee, WI
*Purpose: To determine the impact of Vancomycin Resistant Enterococcus (VRE) colonization on 90-day Liver Transplant (LT) waitlist outcomes.*Methods: Single center, retrospective observational study of LT…
2019 American Transplant Congress
Hepatic Artery Anastomosis Post-Operative Anatomy Influences Doppler Ultrasound Systolic Acceleration Time after Liver Transplantation
R. A. Choudhury, A. Yule, K. Conzen, E. A. Pomfret, T. L. Nydam
Transplant Surgery, University of Colorado, Aurora, CO
*Purpose: Prolongation of the systolic acceleration time (SAT) and decreased resistive index (R/I) of the proper hepatic artery following liver transplant have been associated with…
2019 American Transplant Congress
Resource Utilization in Hepatocellular Carcinoma Liver Transplantation before and after the Six Month Wait Time
J. Sokolich¹, W. McClellan², J. Buggs¹, E. Rogers¹, K. Barber¹, K. Cocuy¹, A. Kumar²
¹Tampa General Hospital, Tampa, FL, ²University of South Florida, Tampa, FL
*Purpose: The purpose of this study was to determine any difference in resource utilization since the implementation of the mandatory six month wait-time policy for…
2019 American Transplant Congress
Anti-Xa Level Monitoring for Treatment Dose Enoxaparin in Liver/Intestine Transplant Recipients
J. Sullivan, J. Jebrock, J. Revollo, M. Perez, J. Garcia, T. Beduschi
Jackson Memorial Hospital, Miami, FL
*Purpose: Evaluate the use of anti-Xa levels in therapeutic enoxaparin dosing in liver/intestine transplant recipients.*Methods: A single-center retrospective chart review was conducted on liver/intestine transplant…
2019 American Transplant Congress
Mismatched Antibody Epitopes and the Development of HLA-DQ De Novo DSA during Immunosuppression Withdrawal in Liver Transplant Recipients
V. Jucaud¹, A. Shaked², M. DesMarais³, P. Sayre⁴, S. Feng⁴, J. Levitsky⁵, M. Everly¹
¹Terasaki Research Institute, Los Angeles, CA, ²University of Pennsylvania, Philadelphia, PA, ³Immune Tolerance Network, San Francisco, CA, ⁴University of California San Francisco, San Francisco, CA, ⁵Northern Western University, Chicago, IL
*Purpose: We recently described, in liver transplant (LT) recipients from the ITN030ST study, the development of de novo donor-specific HLA antibodies (dnDSA) and their impact…
2019 American Transplant Congress
Molecular Analysis of Rejection and Injury in Human Liver Transplant Biopsies: First Results of the INTERLIVER Study
P. F. Halloran and The INTERLIVER Study Group
University of Alberta, Edmonton AB, AB, Canada
*Purpose: The relationship of histologic liver transplant biopsy assessments to actual rejection and injury is unclear. Recent progress in molecular reclassification of kidney, heart, and…
2019 American Transplant Congress
Prospective Multi-Regional Study of Down-Staging of Hepatocellular Carcinoma to within Milan Criteria before Liver Transplantation
N. Mehta¹, J. Guy², C. Frenette³, P. Tabrizian⁴, M. Hoteit⁵, R. Dhanasekaran⁶, J. Dodge¹, M. L. Holzner⁴, L. Frankul³, S. Florman⁴, N. Parikh⁷, F. Yao¹
¹UCSF, San Francisco, CA, ²CPMC, San Francisco, CA, ³Scripps Hospital, La Jolla, CA, ⁴Mt Sinai, New York, NY, ⁵U. Pennsylvania, Philadelphia, PA, ⁶Stanford, Palo Alto, CA, ⁷U. Michigan, Ann Arbor, MI
*Purpose: Recent studies from United Network of Organ Sharing (UNOS) Region 5 reported excellent outcomes after liver transplantation (LT) after successful down-staging in HCC patients…
2019 American Transplant Congress
Preemptive Therapy is Cost Effective When Compared to Prophylaxis in Cytomegalovirus Donor Positive – Recipient Negative Liver Transplant Recipients
M. M. Wagener¹, D. J. Winston², R. R. Razonable³, G. M. Lyon III⁴, F. P. Silveira⁵, A. P. Limaye⁶, N. Singh¹
¹ID, U Pittsburgh and VAPHS, Pittsburgh, PA, ²ID, UCLA, Los Angeles, CA, ³ID, Mayo Clinic, Rochester, MN, ⁴ID, Emory, Atlanta, GA, ⁵ID, U Pittsburgh, Pittsburgh, PA, ⁶ID, U Washington, Seattle, WA
*Purpose: To compare the cost effectiveness of preemptive therapy (PET) vs prophylaxis for the prevention of cytomegalovirus (CMV) in high-risk donor seropositive/recipient seronegative (D+R-) liver…
2019 American Transplant Congress
No Gains In Long-term Survival Of Pediatric Patients After Liver Transplantation – A Three Decade Analysis
S. Bakhtiyar, A. Rana, S. Ahmed, H. Naseem, M. Kueht, N. T. Galvan, R. T. Cotton, C. A. O'Mahony, J. A. Goss
Baylor College of Medicine, Houston, TX
*Purpose: The aim of this study was to assess improvements in long-term survival of pediatric patients after liver transplantation, by analyzing outcomes in transplant recipients…
2019 American Transplant Congress
Treatment Modality Affects Outcomes of Recurrent Hepatocellular Carcinoma Following Liver Transplantation: A US Multicenter Analysis of 2786 Patients
P. Tabrizian¹, K. J. Halazun², M. L. Holzner¹, N. Mehta³, F. Y. Yao³, J. Roberts³, J. C. Emond⁴, B. Samstein², R. S. Brown⁴, S. Florman¹, M. E. Schwartz¹, M. M. Doyle⁵, W. C. Chapman⁵, M. Najjar⁴, R. W. Busuttil⁶, V. G. Agopian⁶
¹Transplant, Mount Sinai Medical Center, New York, NY, ²Transplant, Weill Cornell Medicine, New York, NY, ³Transplant, University of California San Francisco, San Francisco, CA, ⁴Transplant, Columbia University Medical Center, New York, NY, ⁵Transplant, Washington University School of Medicine, St Louis, MO, ⁶Transplant, David Geffen School of Medicine at UCLA, Los Angeles, CA
*Purpose: Recurrent hepatocellular carcinoma (HCC) following liver transplantation (LT) has a poor prognosis. We evaluated the impact of treatment modalities on post-recurrence survival.*Methods: Adult patients…